Notice: Prescription Drug List (PDL): Casirivimab and Imdevimab (COVID-19) (French, HTML)

View metadata and access the original French HTML file: Notice: Prescription Drug List (PDL): Casirivimab and Imdevimab (COVID-19).

Format

HTML

Access

file-only

Publisher-reported update

2023-09-30

The purpose of this Notice of Amendment is to notify about the addition of casirivimab and imdevimab to the Prescription Drug List (PDL) for human and veterinary use.

Access original file